Thompson Investment Management Inc. lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 49,811 shares of the company’s stock after selling 244 shares during the quarter. Thompson Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $3,894,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. LGT Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC grew its holdings in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Stock Performance
GEHC opened at $87.64 on Friday. The business’s 50 day moving average is $83.34 and its 200-day moving average is $85.25. The stock has a market cap of $40.04 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55.
GE HealthCare Technologies Increases Dividend
Wall Street Analysts Forecast Growth
GEHC has been the topic of a number of analyst reports. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $96.00.
View Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
- Five stocks we like better than GE HealthCare Technologies
- Retail Stocks Investing, Explained
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is a buyback in stocks? A comprehensive guide for investors
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.